Physician profile
Jonathan Luker
NPI 1992071732
$1,911.09
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $564 · 2023: $680 · 2024: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $404.66 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $320.17 | 2021-2024 | Xifaxan, Trulance |
| Amgen INC. | $195.11 | 2023-2024 | Repatha, Otezla |
| Teva Pharmaceuticals USA, INC. | $190.52 | 2022-2024 | Austedo Xr, Austedo |
| Novo Nordisk INC | $164.95 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $148.38 | 2022-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $119.54 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.72 | 2021-2023 | Jardiance |
| Exact Sciences Corporation | $85.22 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $44.13 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.41 | 2023-2024 | Eliquis |
| Biogen, INC. | $38.78 | 2023 | Spinraza |
| Axsome Therapeutics, INC. | $20.08 | 2024 | Sunosi |
| Bioventus LLC | $18.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.80 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Luker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.